Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Goodwill: 2023-2025

Historic Goodwill for bioAffinity Technologies (BIAF) over the last 2 years, with Sep 2025 value amounting to $1.4 million.

  • bioAffinity Technologies' Goodwill changed negligibly% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.4 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that bioAffinity Technologies reported Goodwill of $1.4 million as of Q3 2025, which was down 0.00% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Goodwill registered a high of $1.4 million during Q4 2023, and its lowest value of $1.1 million during Q3 2023.
  • Its 3-year average for Goodwill is $1.4 million, with a median of $1.4 million in 2025.
  • Data for bioAffinity Technologies' Goodwill shows a peak YoY increased of 22.28% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows bioAffinity Technologies' Goodwill stood at $1.4 million in 2023, then remained steady at $1.4 million in 2024, then remained steady at $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.4 million for Q2 2025, and $1.4 million during Q1 2025.